-
Overdose-Reversal Drug Narcan Approved for Over-the-Counter Sale

(Photo credit: Next Distro/Unsplash) Loading… -
Tech Companies Ditch AI Ethics Staff As Panic Rises

(Photo Credit: Emiliano Vittoriosi/Unsplash) Loading… -
Jamie Dimon, Banking Crisis Action Hero?

(Photo credit: Joe Mabel/Flickr) Loading… -
Pope in A Puffer Ignites Fresh Debate on ‘Deepfakes’

(Photo Credit: Ed Hardie/Unsplash) Loading… -
Whither the Trump Indictment?

Photo credit: zacklur/Flickr Loading… -
Alibaba to Split into Six Different Entities

Photo credit: UNCTAD/Flickr Loading… -
American Gaming Association Puts a Stop to Collegiate Partnerships

(Photo credit: World Poker Tour/Flickr) Loading… -
CFTC Sues Binance Over Regulatory Violations

Photo credit: Marco Verch/Flickr Loading… -
Uber Eats Cracks Down on Virtual Brands

Photo credit: dronepicr/Flickr Loading… -
Visa’s AI spending temptress
Loading… -
What’s at Play in The Board Game Renaissance?

(Photo Credit: Maria Lin Kim/Unsplash) Loading… -
Luxury Brands Prepare to Cash Out During King’s Coronation

Photo credit: Jimmy Harris/Flickr Loading… -
Investors Pour into Money Market Funds Amid Bank Crisis

Image Credit: iStock, Andrey Maximenko Loading… -
Do Anti-ESG States Know They’re Facing Some of the Worst Climate Change Hazards?

Image Credit: iStock, martin_33 Loading… -
Cash App is Lying to Investors and Abetting Crime, Short Seller Says

Photo credit: JD Lasica/Flickr Loading… -
The Semiconductor Industry Wants To Water Down “Forever Chemicals” Regulation

(Photo Credit: Chris Reid/Unsplash) Loading…
Advisor Upside
Financial advisor news, market insights, and practice management essentials.
-
Can ‘Terror Management Theory’ Explain Inheritance Spending?

Photo by Yunus Tuğ via Unsplash Loading… -
Meet the BlackRock ETF Taking Aim at Invesco’s QQQ

Photo via Erik McGregor/Sipa USA/Newscom Loading… -
Neurocrine Scoops Up Hunger-Drug Maker in Latest Multi-Billion-Dollar Pharma Deal

Photo via Andre M. Chang/ZUMAPRESS/Newscom Loading…




















